For nearly four years, a young woman in Hyderabad walked with what looked like an unusual rhythm, almost as if she were ...

Last year, AstraZeneca reported that a new drug to treat Wilson disease developed by its Alexion rare diseases unit had hit the mark in a phase 3 trial, setting it on course for regulatory filings.